Andrew P Bradford Selected Research

E2F Transcription Factors

1/2018	Differential requirement for dimerization partner DP between E2F-dependent activation of tumor suppressor and growth-related genes.
1/2017	The phosphatidyl inositol 3 kinase pathway does not suppress activation of the ARF and BIM genes by deregulated E2F1 activity.
9/2015	Identification of novel target genes specifically activated by deregulated E2F in human normal fibroblasts.
7/2014	Cancer cell specific cytotoxic gene expression mediated by ARF tumor suppressor promoter constructs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew P Bradford Research Topics

Disease

15	Neoplasms (Cancer) 01/2021 - 03/2006
11	Obesity 01/2022 - 04/2013
9	Endometrial Neoplasms (Endometrial Cancer) 01/2021 - 12/2006
5	Carcinogenesis 10/2012 - 05/2007
3	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2022 - 01/2017
3	Leiomyoma (Uterine Fibroids) 10/2019 - 06/2009
2	Congenital Abnormalities (Deformity) 01/2022 - 08/2015
2	Hyperinsulinism (Hyperinsulinemia) 01/2022 - 01/2017
2	Hyperlipidemias (Hyperlipidemia) 01/2022 - 01/2017
2	Insulin Resistance 01/2022 - 01/2021
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2017
1	Pregnancy Complications 01/2022
1	Weight Cycling 01/2022
1	Inflammation (Inflammations) 01/2021
1	Leiomyosarcoma 10/2019
1	Metabolic Bone Diseases (Osteopenia) 08/2015
1	Infertility (Sterility) 01/2015
1	Weight Gain 01/2015
1	Hyperplasia 01/2013
1	Endometrial Hyperplasia 01/2013
1	Microsatellite Instability 10/2012
1	Neoplasm Metastasis (Metastasis) 07/2012
1	Tics (Tic) 07/2012
1	Breast Neoplasms (Breast Cancer) 07/2012
1	Adenocarcinoma 12/2009
1	Endometrioid Carcinoma 01/2008
1	Pituitary Neoplasms (Pituitary Adenoma) 10/2003

Drug/Important Bio-Agent (IBA)

4	LipidsIBA 01/2022 - 01/2017
4	E2F Transcription FactorsIBA 01/2018 - 07/2014
4	Protein Kinase CIBA 01/2013 - 12/2006
3	Insulin (Novolin)FDA Link 01/2022 - 01/2021
3	Hormones (Hormone)IBA 01/2022 - 05/2007
3	GonadotropinsIBA 01/2021 - 08/2016
3	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2021 - 05/2014
3	Proteins (Proteins, Gene)FDA Link 10/2019 - 05/2007
3	Protein Kinase C-alphaIBA 12/2009 - 12/2006
2	Heparin (Liquaemin)FDA LinkGeneric 01/2022 - 01/2017
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2022 - 04/2018
2	Follicle Stimulating Hormone (Follitropin)FDA Link 01/2021 - 01/2017
2	Luteinizing Hormone (Lutropin)FDA LinkGeneric 01/2021 - 01/2017
2	RNA (Ribonucleic Acid)IBA 10/2019 - 01/2015
2	Estrogens (Estrogen)FDA Link 11/2015 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 01/2015 - 01/2014
2	MicroRNAs (MicroRNA)IBA 01/2015 - 05/2012
2	Phosphotransferases (Kinase)IBA 07/2012 - 06/2009
2	Protein Isoforms (Isoforms)IBA 12/2009 - 12/2006
2	Protein Kinase C-deltaIBA 06/2009 - 01/2008
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 03/2006 - 10/2003
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022
1	Growth Hormone (Somatotropin)IBA 01/2022
1	CreatinineIBA 01/2022
1	ProlactinIBA 01/2022
1	Thyroid HormonesIBA 01/2022
1	AdiponectinIBA 01/2022
1	LeptinIBA 01/2022
1	lorecivivintIBA 01/2021
1	CateninsIBA 01/2021
1	beta CateninIBA 01/2021
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2020
1	Aromatase (CYP19)IBA 01/2020
1	TESIBA 10/2019
1	Progesterone FDA LinkGeneric 08/2016
1	FructoseIBA 01/2015
1	Messenger RNA (mRNA)IBA 01/2015
1	cetrorelix (Cetrotide)FDA Link 05/2014
1	ElementsIBA 01/2013
1	Estrogen ReceptorsIBA 01/2013
1	NucleotidesIBA 10/2012
1	DNA (Deoxyribonucleic Acid)IBA 10/2012
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2012
1	Phenobarbital (Luminal)FDA Link 07/2012
1	Transforming Growth Factor beta (TGF-beta)IBA 07/2012
1	Mitogen-Activated Protein KinasesIBA 07/2012
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 07/2012
1	AZD 6244IBA 07/2012
1	U 0126 (UO 126)IBA 07/2012
1	SteroidsIBA 07/2009
1	JNK Mitogen-Activated Protein KinasesIBA 06/2009
1	Indicators and Reagents (Reagents)IBA 01/2008
1	delta proteinIBA 01/2008
1	Etoposide (VP 16)FDA LinkGeneric 01/2008
1	Proto-Oncogene Proteins c-etsIBA 05/2007
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 03/2006

Therapy/Procedure

2	Therapeutics 01/2017 - 10/2012
1	Minimally Invasive Surgical Procedures 10/2019
1	Braces 08/2015
1	Oncolytic Virotherapy 07/2014
1	Hysterectomy 06/2009